Wire Stories

Category Added in a WPeMatico Campaign

news_6

IASO Biotherapeutics Application for Clinical Trials of the Second Indication of its Fully Human CD19/CD22 Dual-targeted CAR-T Drug Accepted by NMPA

PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)--#Biopharmaceutical--IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell...

news_6

Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

news_6

EBON FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ebang International Holdings Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action – EBON

NEW YORK--(BUSINESS WIRE)--#EBON--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ebang International...

news_6

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Ebang International Holdings, Inc. and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit...